Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
This year’s theme is ‘A Holistic Approach to Plasma Cell Disorders’ and brings together UK and international experts to explore current practice, emerging evidence and practical approaches to holistic care for people with plasma cell disorders. Designed for haematology teams, the programme covers updates in myeloma management, drug delivery, frailty assessment and the wider spectrum of monoclonal gammopathies.
Sessions include UK clinical and trials updates, guideline-focused talks, exercise management, outreach haematology and immunoglobulin replacement. The event also features presentations from ASH abstract winners, including research on long-read RNA sequencing in newly diagnosed myeloma and AI-based biomarker discovery for cardiac amyloidosis.
The Michael Morley Lecture will focus on assessing frailty in real-world practice and its implications for treatment decisions. Afternoon sessions provide concise updates across monoclonal gammopathies of cutaneous and renal significance, POEMS and associated coagulopathies.
This hybrid format offers opportunities for in-person networking as well as online participation.
Who should attend
Haematology consultants, CNSs, pharmacists, AHPs and other professionals involved in diagnosing, treating and supporting people with plasma cell disorders.
